Article
CFTR pharmacological modulators: A great advance in cystic fibrosis management.
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie - 1 Jan 2023
Foucaud P, Mercier J C
Abstract excerpt
Cystic fibrosis is a severe monogenic disease that affects around 7400 patients in France. More than 2100 mutations in the cystic fibrosis conductance transmembrane regulator (CFTR), the gene encoding for an epithelial ion channel that normally transports chloride and bicarbonate, lead to mucus dehydration and impaired bronchial clearance. Systematic neonatal screening in France since 2002 has enabled early...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
